Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia
Elizabeth F. Krakow(Fred Hutch Cancer Center), Brenda M. Sandmaier(University of Washington), Thomas R. Chauncey(City Of Hope National Medical Center), Elihu H. Estey(University of Washington), Boglarka Gyurkocza(Cornell University), Barry E. Storer(City Of Hope National Medical Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jerald P. Radich(University of Washington), David G. Maloney(Fred Hutch Cancer Center), M Bouvier(Fred Hutch Cancer Center), Jeannine S. McCune(City of Hope)
Cited by 7
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k